Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $1.64 Million - $1.88 Million
-8,264 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $471,239 - $552,114
2,220 Added 36.73%
8,264 $1.76 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $40,642 - $45,090
174 Added 2.96%
6,044 $1.47 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $219,247 - $255,496
988 Added 20.24%
5,870 $1.46 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $435,356 - $518,432
2,012 Added 70.1%
4,882 $1.12 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $673,445 - $748,926
2,870 New
2,870 $729,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.